Indian Journal of Endocrine Surgery and Research

Register      Login

VOLUME 17 , ISSUE 1 ( January-June, 2022 ) > List of Articles


Case Report of Rare Hereditary Endocrine Cancer Syndrome: Multiple Endocrine Neoplasia Type 2B

Shreya Surendra, Priyanka Rohit Singh, Supriya Sen, Varghese Thomas, Shawn Sam Thomas, Deepak Thomas Abraham, MJ Paul

Keywords : Medullary thyroid carcinoma, Mucosal neuromas, Multiple endocrine neoplasia type 2B

Citation Information : Surendra S, Singh PR, Sen S, Thomas V, Thomas SS, Abraham DT, Paul M. Case Report of Rare Hereditary Endocrine Cancer Syndrome: Multiple Endocrine Neoplasia Type 2B. 2022; 17 (1):14-16.

DOI: 10.5005/jp-journals-10088-11188

License: CC BY-NC 4.0

Published Online: 28-07-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Multiple endocrine neoplasia type 2B (MEN2B) is an extremely rare hereditary thyroid cancer syndrome. The individuals are presented with an aggressive form of medullary thyroid carcinoma (MTC). They have classic morphology features that aid in the diagnosis of the syndrome.

PDF Share
  1. Williams ED, Pollock DJ. Multiple mucosal neuromata with endocrine tumours: a syndrome allied to von Recklinghausen's disease. J Pathol Bacteriol 1966;91(1):71–80. DOI: 10.1002/path.1700910109.
  2. Hansford JR, Mulligan LM. Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet 2000;37(11):817–827. DOI: 10.1136/jmg.37.11.817.
  3. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26(1):1–133. DOI: 10.1089/thy.2015.0020.
  4. Zenaty D, Aigrain Y, Peuchmaur M, et al. Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B. Eur J Endocrinol 2009;160(5):807–813. DOI: 10.1530/EJE-08-0854.
  5. Ito T, Igarashi H, Uehara H, et al. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. Medicine (Baltimore) 2013;92(3):135–181. DOI: 10.1097/MD.0b013e3182954af1.
  6. Brauckhoff M, Machens A, Lorenz K, et al. Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective. Ann Surg 2014;259(4):800–806. DOI: 10.1097/SLA.0b013e3182a6f43a.
  7. Thosani S, Ayala-Ramirez M, Román-González A, et al. Constipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma. Eur J Endocrinol 2015;173(3):377–387. DOI: 10.1530/EJE-15-0456.
  8. Wray CJ, Rich TA, Waguespack SG, et al. Failure to recognize multiple endocrine neoplasia 2B: more common than we think? Ann Surg Oncol 2008;15(1):293–301. DOI: 10.1245/s10434-007-9665-4.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.